Canadian Pharmacists Association
Canadian Pharmacists Association

Supply challenges affecting children's pain and fever medications

Canada has been experiencing supply issues affecting pediatric formulations of both acetaminophen and ibuprofen products.

CPhA is involved in regular discussions with Health Canada and other key stakeholders to address the situation and to discuss mitigation strategies. The current lack of availability of these products is being driven by significantly increased demand due to a surge in respiratory illnesses across the country. Production levels remain higher than usual, and supply continues to arrive intermittently.

Recomendation for pharmacy professionals: We encourage pharmacies to consider placing temporary limits on purchases of these products (e.g., one product per purchase/customer) where appropriate, to help ensure availability for all who require these medications.

CPhA remains committed to working with provincial and federal stakeholders to collaborate on strategies to help alleviate this shortage.

Information and resources

Last updated: November 23, 2022